TLR7 and systemic lupus erythematosus: Increased CD8+ T cell, B cell, monocyte, and DC activity in Black individuals after stimulation of TLR7/8/9 may contribute to increased disease severity and early mortality in Black patients with SLE, and these pathways may be targetable for personalized treatments.